Evidence for IFN-γ up- and IL-4 downregulation late post-transplant in patients with good kidney graft outcome

Clinical Transplantation

Volumn 21, Issue 4, 2007, Pages 449-459

  Sadeghi, Mahmoud ^a   Daniel, Volker ^a   Naujokat, Cord ^a   Schmidt, Jan ^a   Mehrabi, Arianeb ^a   Zeier, Martin ^a   Opelz, Gerhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Long term stable graft function; Plasma IFN c; Plasma IL 4; Renal transplantation; Th1 Th2

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; GAMMA INTERFERON; INTERLEUKIN 4; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CHRONIC GRAFT REJECTION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG BLOOD LEVEL; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; T LYMPHOCYTE ACTIVATION; TH1 CELL; UPREGULATION;

ADULT; BIOLOGICAL MARKERS; DOWN-REGULATION; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-4; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; TH1 CELLS; UP-REGULATION;

EID: 34547457151     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2007.00665.x     Document Type: Article

References (37)

1. Masri MA. The mosaic of immunosuppressive drugs. Mol Immunol 2003: 39: 1073.
2. Tinckam K, Rush D, Hutchinson I et al. The relative importance of cytokine gene polymorphisms in the development of early and late acute rejection and six-month renal allograft pathology. Transplantation 2005: 79: 836.
3. Obata F, Yoshida K, Ohkubo M et al. Contribution of CD4(+) and CD8(+) T cells and interferon-gamma to the progress of chronic rejection of kidney allografts: The Th1 response mediates both acute and chronic rejection. Transpl Immunol 2005: 14: 21.
4. Asderakis A, Sankaran D, Dyer P et al. Association of polymorphisms in the human interferon-gamma and interleukin-10 gene with acute and chronic kidney transplant outcome: The cytokine effect on transplantation. Transplantation 2001: 71: 674.
5. Saggi BH, Fisher RA, Naar JD et al. Intragraft cytokine expression in tolerant rat renal allografts with rapamycin and cyclosporin immunosuppression. Clin Transplant 1999: 13: 90.
6. Noronha IL, Eberlein-Gonska M, Hartley B, Stephens S, Cameron JS, Waldherr R. In situ expression of tumor necrosis factor-alpha, interferon-gamma, and interleukin-2 receptors in renal allograft biopsies. Transplantation 1992: 54: 1017.
7. Daniel V, Naujokat C, Sadeghi M, Wiesel M, Hergesell O, Opelz G. Association of circulating IL-12- and IL-10-producing dendritic cells with time post-transplant, dose of immunosuppression, and plasma cytokines in renal transplant recipients. Transplantation 2005: 79: 1498.
8. Skapenko A, Niedobitek GU, Kalden JR, Lipsky PE, Schulze-Koops H. Generation and regulation of human Th1-biased immune responses in vivo: a critical role for IL-4 and IL-10. J Immunol 2004: 172: 6427.
9. Lang T, Krams SM, Martinez OM. Production of IL-4 and IL-10 does not lead to immune quiescence in vascularized human organ grafts. Transplantation 1996: 62: 776.
10. Almawi WY, Melemedjian OK, Rieder MJ. An alternate mechanism of glucocorticoid anti-proliferative effect: Promotion of a Th2 cytokine-secreting profile. Clin Transplant 1999: 13: 365.
11. Franchimont D. Overview of the actions of glucocorticoids on the immune response: A good model to characterize new pathways of immunosuppression for new treatment strategies. Ann N Y Acad Sci 2004: 1024: 124.
12. Stepkowski SM, Tian L, Napoli KL et al. Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection. Clin Exp Immunol 1997: 108: 63.
13. Daniel V, Pasker S, Wiesel M et al. Cytokine monitoring of infection and rejection in renal transplant recipients. Transplant Proc 1995: 27: 884.
14. Boehm U, Klamp T, Groot M, Howard JC. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 1998: 160: 2059.
15. Nast CC, Zuo XJ, Prehn J, Danovitch GM, Wilkinson A, Jordan SC. Gamma-interferon gene expression in human renal allograft fine-needle aspirates. Transplantation 1994: 57: 498.
16. Wirleitner B, Neurauter G, Schrocksnadel K, Frick B, Fuchs D. Interferon-gamma-induced conversion of tryptophan: Immunologic and neuropsychiatric aspects. Curr Med Chem 2003: 10: 1581.
17. Wood KJ, Sawitzki B. Interferon gamma: A crucial role in the function of induced regulatory T cells in vivo. Trends Immunol 2006: 27: 183.
18. Yu XZ, Albert MH, Martin PJ, Anasetti C. CD28 ligation induces transplantation tolerance by IFN-gamma-dependent depletion of T cells that recognize alloantigens. J Clin Invest 2004: 113: 1624.
19. Xiao BG, Wu XC, Yang JS et al. Therapeutic potential of IFN-gamma-modified dendritic cells in acute and chronic experimental allergic encephalomyelitis. Int Immunol 2004: 16: 13.
20. Pirenne J, Kitade H, Kawai M et al. Regulatory cells, TH1/TH2 unbalance, and antibody-induced chronic rejection in operational tolerance induced by donor-specific blood transfusion. Transplantation 2005: 3 (Suppl.): S25.
21. Hassan AT, Dai Z, Konieczny BT et al. Regulation of alloantigen-mediated T-cell proliferation by endogenous interferon-gamma: Implications for long-term allograft acceptance. Transplantation 1999: 68: 124.
22. Sawitzki B, Kingsley CI, Oliveira V, Karim M, Herber M, Wood KJ. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med 2005: 201: 1925.
23. Corris PA, Kirby JA. A role for cytokine measurement in therapeutic monitoring of immunosuppressive drugs following lung transplantation. Clin Exp Immunol 2005: 139: 176.
24. Noronha IL, Daniel V, Möhring K, Opelz G. Analysis of plasma interleukin-2 receptor (sIL-2R) and tumor necrosis factor-alpha (TNF-α) in renal transplant patients. Clin Transplant 1992: 6: 277.
25. Basile DP. The transforming growth factor beta system in kidney disease and repair: Recent progress and future directions. Opin Nephrol Hypertens 1999: 8: 21.
26. Sadeghi M, Daniel V, Weimer R, Wiesel M, Hergesell O, Opelz G. Pre-transplant Th1 and post-transplant Th2 cytokine patterns are associated with early acute rejection in renal transplant recipients. CLIN Transplant 2003: 17: 151.
27. Brazille P, Dereuddre-Bosquet N, Leport C et al. Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients. Clin Exp Immunol 2003: 131: 304.
28. Hitchon CA, Alex P, Erdile LB et al. A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis. J Rheumatol 2004: 31: 2336.
29. Le Meur Y, Lorgeot V, Aldigier JC, Wijdenes J, Leroux-Robert C, Praloran V. Whole blood production of monocytic cytokines (IL-1beta, IL-6, TNF-alpha, sIL-6R, IL-1Ra) in haemodialysed patients. Nephrol Dial Transplant 1999: 14: 2420.
30. Belardelli F. Role of interferons and other cytokines in the regulation of the immune response. APMIS 1995: 103: 161.
31. Pertosa G, Grandaliano G, Gesualdo L, Schena FP. Clinical relevance of cytokine production in hemodialysis. Kidney Int Suppl 2000: 76: S104.
32. Sadeghi M, Daniel V, Weimer R, Wiesel M, Hergesell O, Opelz G. Differential early post-transplant cytokine responses in living and cadaver donor renal allografts. Transplantation 2003: 75: 1351.
33. Cueto-Manzano AM, Morales-Buenrostro LE, Gonzalez-Espinoza L et al. Markers of inflammation before and after renal transplantation. Transplantation 2005: 80: 47.
34. El-Kady IM, Lotfy M, Badra G, El-Masry S, Waked I. Interleukin (IL)-4, IL-10, IL-18 and IFN-gamma cytokines pattern in patients with combined hepatitis C virus and Schistosoma mansoni infections. Scand J Immunol 2005: 61: 87.
35. Morosini M, Meloni F, Marone Bianco A et al. The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis. Int J Tuberc Lung Dis 2003: 7: 994.
36. Bodolay E, Aleksza M, Antal-Szalmas P et al. Serum cytokine levels and type 1 and type 2 intracellular T cell cytokine profiles in mixed connective tissue disease. J Rheumatol 2002: 29: 2136.
37. Alscher DM, Pauli-Magnus C, Kuhlmann U, Mettang T. Stimulated IFN-gamma and IL-10 secretion of blood mononuclear cells in patients on renal replacement therapies show different secretion patterns. Artif Organs 2000: 24: 767.